Guy Carpenter and A.M. Best have re-issued our joint dedicated reinsurance capital estimate for September 2020 of USD 471 billion, down 2.4 percent since year-end 2019. The recent update and change is the result of additional analysis and mid-year reporting from our initial June forecast. ... Continue Reading »
Pandemic
Digital Tools Can Help Reopen Workplaces Safely, If Businesses Mitigate Risks
The cyber (re)insurance space is constantly developing, and as COVID-19 alters the way businesses interact with technology and workers around the country slowly return to work after months of operating from home offices, the reinsurance market sees a number of emerging trends that present both potential challenges and opportunities. While COVID-19 remains a threat worldwide, ... Continue Reading »
Risk-Based Capital Stress Testing: Part II
The Impact for Life & Health Insurance Companies COVID-19 is likely having an impact on insurance company capital. Companies are closely monitoring potential decreases in assets as well as liability changes in an effort to protect their capital and surplus positions. Rating agencies are also monitoring these developments to try to identify companies whose financial ... Continue Reading »
Capital and The Insurance Industry During COVID-19
Vicky Carter, Guy Carpenter Chairman of Global Capital Solutions, International, recently spoke to Mark Geoghegan, Editor at The Voice of Insurance about capital in the (re)insurance industry during the COVID-19 pandemic. During their discussion, Vicky and Mark examine capital and the industry’s financial health, investor appetite for the insurance sector and the prospects f ... Continue Reading »
Risk-Based Capital Stress Testing: Part I
As companies continue to navigate the repercussions of COVID-19, it is important that they understand the pandemic’s impact on risk-based capital (RBC). Insurers are dealing with COVID-19’s effects on assets and liabilities, both of which can affect capital levels. ... Continue Reading »
Webinar: Managing Cyber Risk in Life Sciences Technology
The cyber risk sector is constantly evolving, and it is crucial for reinsurers to keep up with the latest developments in the space. Looking toward the remainder of 2020 as COVID-19 upends how businesses interact with technology, the reinsurance market sees a number of emerging trends. Life sciences and technology companies are increasingly aligning to pursue advances in ... Continue Reading »
Podcast: Digital Opportunities & Risk During COVID Times
The cyber space saw numerous developments during 2019, including new privacy regulations, systemic ransomware claims and increasing concern surrounding non-affirmative cyber in the underwriting community. Looking toward the remainder of 2020, Guy Carpenter sees a number of emerging trends that present both potential challenges and opportunities for our clients, particularly as ... Continue Reading »
How to Be a Leader in the New World of Work
As businesses seek to address both the immediate and long-term effects of COVID-19 on their operations, the reinsurance industry is at the forefront of conversations to create a forward-looking solution for pandemic risk in conjunction with policyholders, insurance markets and corporate executives. Amid the heartbreaking toll of the global pandemic, organizations are ... Continue Reading »
Cost and Utilization of Healthcare Services During COVID-19
As the COVID-19 pandemic continues through the summer, public health concerns are at the forefront of everyone's mind and Guy Carpenter is actively developing a view of how COVID-19 may impact the healthcare industry and the medical (re)insurance market. In early March, as the United States began coming to grips with the potential impact of the COVID-19 pandemic, many ... Continue Reading »
Asia’s Digital Hospitals Of Tomorrow
As the COVID-19 pandemic appears poised to continue into the fall, the reinsurance industry is collaborating with healthcare executives on how to mitigate the effects of the virus on the sector, and telemedicine and virtual care solutions have proved themselves to be viable healthcare options, though costs are currently high. ... Continue Reading »
